Page last updated: 2024-08-25

chitosan and Depression

chitosan has been researched along with Depression in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Li, PF; Liu, XY; Qi, XJ; Qiu, F; Tang, LM; Yang, AH1
Abd Rabo, AA; Abd-El Daim, TM; Elfeky, AS; Fahmy, HM; Khadrawy, YA; Mostafa, IT; Mustafa, AB1
Abbas, H; El-Naa, M; Kamel, R1
da Costa Araújo, AP; da Silva, IC; de Melo, NFS; Estrela, FN; Fraceto, LF; Guimarães, ATB; Lima, VS; Malafaia, G1
Mishra, D; Nagpal, K; Singh, SK1
Hallan, SS; Mehra, NK; Mishra, N; Prakash, A; Rashid, M; Singh, D1

Other Studies

6 other study(ies) available for chitosan and Depression

ArticleYear
Anti-depressant effect of curcumin-loaded guanidine-chitosan thermo-sensitive hydrogel by nasal delivery.
    Pharmaceutical development and technology, 2020, Volume: 25, Issue:3

    Topics: Administration, Intranasal; Animals; Antidepressive Agents; Chitosan; Curcumin; Depression; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Guanidine; Hydrogels; Male; Mice; Mice, Inbred ICR; Solubility; Temperature; Viscosity

2020
Thymoquinone-encapsulated chitosan nanoparticles coated with polysorbate 80 as a novel treatment agent in a reserpine-induced depression animal model.
    Physiology & behavior, 2020, 08-01, Volume: 222

    Topics: Animals; Benzoquinones; Chitosan; Depression; Disease Models, Animal; Nanoparticles; Polysorbates; Rats; Reserpine

2020
Composite carbohydrate interpenetrating polyelectrolyte nano-complexes (IPNC) as a controlled oral delivery system of citalopram HCl for pediatric use: in-vitro/in-vivo evaluation and histopathological examination.
    Drug delivery and translational research, 2018, Volume: 8, Issue:3

    Topics: Administration, Oral; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain; Chitosan; Citalopram; Delayed-Action Preparations; Depression; Drug Liberation; Male; Nanostructures; Pectins; Polyelectrolytes; Rats; Selective Serotonin Reuptake Inhibitors

2018
Depression, anxiety-like behavior, and memory impairment in mice exposed to chitosan-coated zein nanoparticles.
    Environmental science and pollution research international, 2019, Volume: 26, Issue:11

    Topics: Animals; Anxiety; Behavior, Animal; Chitosan; Depression; Male; Memory Disorders; Mice; Nanoparticles; Zein

2019
Evaluation of safety and efficacy of brain targeted chitosan nanoparticles of minocycline.
    International journal of biological macromolecules, 2013, Volume: 59

    Topics: Animals; Anti-Bacterial Agents; Antidepressive Agents; Behavior, Animal; Brain; Chitosan; Depression; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Drug Repositioning; Hindlimb Suspension; Locomotion; Male; Mice; Minocycline; Monoamine Oxidase; Nanoparticles; Polysorbates; Rats; Treatment Outcome

2013
Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression.
    Artificial cells, nanomedicine, and biotechnology, 2016, Volume: 44, Issue:3

    Topics: Administration, Intranasal; Animals; Antidepressive Agents; Chitosan; Depression; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Nanoparticles; Rats; Rats, Wistar; Selegiline

2016